News Hub | News Direct

Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device

Nexalin Technology

Nexalin Technology CEO Mark White joined Steve Darling from Proactive to share positive results from a clinical study evaluating Nexalin’s Gen-2 tACS device for reducing pain in veteran patients with Mild Traumatic Brain Injury (mTBI). The study was conducted at The University of California, San Diego, and involved collaboration with the United States Department of Veterans Affairs (VA) San Diego Healthcare System, as well as the Radiology, Psychiatry, and Neurosciences Departments of UC San Diego. mTBI is a significant concern for veterans and the general public, leading to various physical, cognitive, emotional, and behavioral deficits. However, effective treatments for post-concussive symptoms (PCS) are limited, and the underlying pathophysiology is not fully understood. Symptoms of PCS often overlap with those of post-traumatic stress disorder (PTSD), further complicating diagnosis and treatment. The clinical trial was conducted as a randomized, double-blind, placebo-controlled study over an eight-week period, involving two groups: an active tACS group and a sham tACS group. Twenty-four veteran patients with mTBI received twelve sessions of either active or sham tACS over four consecutive weeks, followed by a four-week follow-up period to assess outcomes. The positive results from this study are significant, especially considering the substantial market potential for treatments addressing traumatic brain injuries. According to Global Market Insights, the Traumatic Brain Injuries Assessment Market is projected to reach over $7.2 billion by 2032. Nexalin's innovative approach offers promise in addressing the needs of individuals suffering from mTBI, potentially improving their quality of life and providing hope for effective treatment options in the future. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

April 04, 2024 11:05 AM Eastern Daylight Time

Video

Cavitation Technologies Enhances Fluid Processing Efficiency with Green Tech

Cavitation Technologies, Inc.

Cavitation Technologies CEO Neil Voloshin joined Steve Darling from Proactive to share updates about the company's advanced fluid processing technologies with Steve Darling from Proactive. Established in 2008 and publicly traded under the symbol CVAT, Cavitation Technologies specializes in enhancing the efficiency of fluid processing applications without altering existing processes. The company's technology operates by modifying the physical or molecular structure of fluids, facilitating rapid chemical reactions, and reducing the need for chemicals in various applications. Voloshin explained that the core technology involves fluid passing through a cylinder where energy is generated, leading to the formation of nanoparticles or micro-vapor bubbles. This innovative process can handle fluid capacities ranging from 10 to 500 gallons per minute, offering versatile applications in water remediation, agriculture, vegetable oil refining, and alcoholic beverages. Highlighting recent achievements, Voloshin mentioned a three-year renewal agreement with Desmet Ballestra from Belgium, which is expected to generate approximately $1 million in revenue for the year. He also noted that Cavitation Technologies operates with fixed annual costs of $600,000 and enjoys high gross margins of 80-85%. Looking ahead to 2024, Voloshin expressed optimism about significant advancements in water remediation for fracking, produced water treatment, and agriculture. The company is actively engaged with government agencies and universities, focusing on developing more efficient processes that contribute to environmental sustainability. Cavitation Technologies aims to continue its trajectory of innovation and growth in the fluid processing industry. Contact Details Proactive North America Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

April 04, 2024 11:03 AM Eastern Daylight Time

Video

Robot Dog Saves Lives in Massachusetts Standoff

MarketJar

A robotic dog named Roscoe from the Massachusetts State Police Bomb Squad is being praised for its role in averting a potential tragedy involving a person barricaded in a home. 1 On March 6, the Massachusetts State Police sent Roscoe into a home where a 30-year-old man, who had allegedly held his mother at knifepoint, was located. The suspect shot the robot three times, partially disabling it. State police noted that deploying Roscoe potentially saved the lives of officers and real dogs involved in the incident. Boston Dynamics, the company behind the Spot robot, stated that it was the first time one of their robots had been shot. The company expressed relief that the only casualty was their robot. Roscoe has been sent to Boston Dynamics for repairs, and a new unit will be provided to the state police. Robots are increasingly being used by law enforcement agencies nationwide. In New York City, Digidogs have been employed since 2023 to help de-escalate situations. Similarly, law enforcement agencies in Florida, Los Angeles, and other states have utilized these cybernetic hounds. 2 Another company deploying AI-powered robots and emergency systems to deter crime across the US is Knightscope, Inc. (NASDAQ:KSCP), a leading innovator in robotics and artificial intelligence (AI) technologies focused on public safety. Knightscope ’s autonomous security robots (ASRs) use a unique combination of self-driving technology, robotics, AI, and electric vehicles to provide humans with extra eyes, ears and a voice on the ground. Innovative Robot Company Progresses on Path to Profitable Expansion Knightscope deployed its first Autonomous Security Robots in May 2015 and has continued signing contracts since with major clients across the country. The company’s ASRs, Blue Light Tower emergency phones and Automated Gunshot Detection (AGD) technology is already being utilized in public spaces including schools, hospitals, HOAs, casinos, transportation hubs and places of worship. On April 4, Knightscope, Inc. (NASDAQ:KSCP) announced 18 new contracts and five new renewal agreements that are valued at over $1 million. The announcement comes off the back of a successful Innovation Week held by the company and its FY 2023 results, adding substantial growth in its top line revenue through new contracts. These contracts predominantly hail from rapidly expanding sectors like transportation, healthcare, education, and local government, which not only form the bulk of the current agreements but also offer numerous prospects for further expansion across both individual clients and their markets. Earlier this week, Knightscope, Inc. (NASDAQ:KSCP) reported its financial results for 2023, showcasing significant progress towards profitability and operational efficiency. Knightscope reported total revenue of $12.8 million, marking a substantial 128% increase from the previous year. This growth was driven by a $2 million increase in net revenue from services, totaling $7.2 million, and a $5.2 million increase in net revenue from product sales, totaling $5.6 million. The surge in product sales was attributed to the integration of Emergency Communication Devices (ECDs) into their product lines following the acquisition of CASE Emergency Management Systems. Total operating expenses for the year amounted to $24.3 million, a $4.4 million reduction from the previous year. This reduction was driven by lower sales and marketing costs and R&D expenses, leading to operating expenses as a percentage of revenue dropping from 509% to 190%. Looking ahead to 2024, Knightscope has outlined a growth strategy focused on organizational restructuring, service optimization, manufacturing consolidation, and facility reduction. These initiatives aim to reduce payroll expense by over 30%, align support for key technologies with service contracts, and improve manufacturing efficiency and facility utilization. Knightscope also plans to bolster its product offering further after signing an MOU with Draganfly (NASDAQ: DPRO), an award-winning industry leading drone developer. The company plans to integrate Draganfly’s drone technology with its ASR tech to create Autonomous Security Drones. For further information on Knightscope 's innovative solutions and projects, please visit Knightscope's website (NASDAQ:KSCP). Footnotes: [1] https://www.ctvnews.ca/mobile/world/robot-police-dog-shot-credited-with-averting-potential-tragedy-1.6825781?cache=sstyoxrk?clipId=89563 [2] https://www.usatoday.com/story/tech/2024/03/28/what-to-know-about-spot-the-robotic-dog/73118781007/ Disclosure: 1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies outlined in this Article. The author determined which companies would be included in this article based on research and understanding of the sector. 2) The Article was issued on behalf of and sponsored by, Knightscope, Inc. Market Jar Media Inc. was paid $1,500 for the production and publishing of this article by Knightscope, Inc.’s Digital Marketing Agency of Record (Native Ads Inc.). Additional details relating to Market Jar Media Inc.’s engagement by Knightscope, Inc.’s Digital Marketing Agency of Record (Native Ads Inc.) are set out in https://pressreach.com/disclaimer-kscp. 3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy. 4) The Article does not constitute investment advice. All investments carry risk and each reader is encouraged to consult with his or her individual financial professional. Any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on PressReach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on PressReach.com. 5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article. 6) This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect management's expectations regarding Knightscope, Inc.’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to Knightscope, Inc.’s industry; (b) market opportunity; (c) Knightscope, Inc.’s business plans and strategies; (d) services that Knightscope, Inc. intends to offer; (e) Knightscope, Inc.’s milestone projections and targets; (f) Knightscope, Inc.’s expectations regarding receipt of approval for regulatory applications; (g) Knightscope, Inc.’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) Knightscope, Inc.’s expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute Knightscope, Inc.’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) Knightscope, Inc.’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) the accuracy of budgeted costs and expenditures; (e) Knightscope, Inc.’s ability to attract and retain skilled personnel; (f) political and regulatory stability; (g) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (h) changes in applicable legislation; (i) stability in financial and capital markets; and (j) expectations regarding the level of disruption to as a result of CV-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of Knightscope, Inc. to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) Knightscope, Inc.’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as CV-19 may adversely impact Knightscope, Inc.’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing Knightscope, Inc.’s business operations (e) Knightscope, Inc. may be unable to implement its growth strategy; and (f) increased competition.Except as required by law, Knightscope, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither does Knightscope, Inc. nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. Neither Knightscope, Inc. nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this document by you or any of your representatives or for omissions from the information in this document. 7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of Knightscope, Inc. or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of Knightscope, Inc or such entities and are not necessarily indicative of future performance of Knightscope, Inc. or such entities. 8) Investing is risky. The information provided in this article should not be considered as a substitute for professional financial consultation. Users should be aware that investing in any form carries inherent risks, and as such, there is a possibility of losing some or all of their investment. The value of investments can fluctuate significantly within a short period, and investors must understand that past performance is not indicative of future results. Additionally, users should exercise caution as transactions involving investments may be irreversible, even in cases of fraud or accidental actions. It is crucial to acknowledge that rapidly evolving laws and technical issues can have adverse effects on the usability, transferability, exchangeability, and value of investments. Furthermore, users must be cognizant of potential security risks associated with their investment activities. Individuals are strongly encouraged to conduct thorough research, seek professional advice, and carefully evaluate their risk tolerance before engaging in any investment endeavors. Market Jar Media Inc. is neither an investment adviser nor a broker-dealer. The information presented on the website is provided for informative purposes only and is not to be treated as a recommendation to make any specific investment. No such information on PressReach.com constitutes advice or a recommendation. Contact Details James Young +1 800-340-9767 campaigns@pressreach.com Company Website https://pressreach.com

April 04, 2024 10:00 AM Eastern Daylight Time

Image

News Release

Above Food files Amendment No. 4 to the Form F-4 Registration Statement in connection with its Proposed Business Combination with Bite Acquisition Corp.

Above Food Corp.

New York, NY and Regina, SK – TheNewswire - (April 4, 2024) –– Above Food Corp. (“Above Food” or the “Company”), an innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients and consumer products, and Bite Acquisition Corp. (NYSE AMERICAN: BITE) (“Bite”), a special purpose acquisition company, announced today the filing by Above Food Ingredients Inc., a direct wholly owned subsidiary of Above Food (“New Above Food”), of Amendment No. 4, filed on April 1, 2024, to the Form F-4 registration statement (as amended from time to time, the “Registration Statement”), which contains a preliminary proxy statement of Bite and a prospectus of Above Food in connection with the previously announced business combination of Above Food and Bite (the “Business Combination”). Upon the closing of the proposed Business Combination, New Above Food will become a public company and is expected to be listed on the New York Stock Exchange under the ticker symbol “ABVE”. While the Registration Statement has not yet become effective, and the information contained therein is subject to change, it provides important information about Above Food’s business, differentiated seed-to-fork platform, intellectual property, and vertically integrated manufacturing capabilities, as well as the proposed Business Combination, and the proposals to be considered by Bite's shareholders. Lionel Kambeitz, Chief Executive Officer at Above Food, said "with the filing of the fourth amendment to the Form F-4 following so closely on the heels of our previous amendment, we are finalizing the go-public process and anticipate a successful listing shortly." The proposed Business Combination implies a pro forma enterprise value of approximately US$319 million. Consideration will be 100% in the form of rollover shares, and the proposed Business Combination is expected to provide approximately US$44 million of gross proceeds to fund future facility development and working capital. Above Food has already received US$9.5 million of investments from several high-profile strategic and financial investors, including Lexington Capital (an alternative investments and development group focused on food & agriculture, water and real estate) and Grupo Vida (one of the largest oat manufacturers in the Americas with production and facilities in Mexico, Canada and Chile). These investors' financial commitment to Above Food is expected to generate commercial and operational synergies for Above in the years to come. Above Food’s Investment Highlights Above Food is a scaled, innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients to ~260 customers globally and consumer products to ~35,000 retail points of distribution. Well-positioned in a high-growth, US$200 billion plant-based market with multiple macroeconomic demand drivers, including food scarcity and insecurity, global supply chain disruption, ESG and sustainability and deepening sector appeal. Above Food’s vertically integrated sourcing, traceability systems, and regenerative supply chain enables a “Seed-to-Fork” platform that supports a complementary portfolio of ingredients and consumer products. Verification of quality and integrity through extensive food safety and food supply certifications, including BRC AA, HACCP, Regenerative Organic Certified (ROC), Gluten Free Certification Organization (GFCO), USDA Organic, Certified Kosher (COR), Vegan, Tested Glyphosate Clean, and Non-GMO Verified. Ownership and control of proprietary seed genetics, and ongoing trait improvements through agronomy, production protocols and natural genetic selection. Established global distribution network and customer contracts drive revenue predictability. Advisors EarlyBirdCapital, Inc. is acting as financial advisor and capital markets advisor to Bite. Roth Capital Partners, LLC will act as lead placement agent, and ATB Capital Markets USA Inc., EarlyBirdCapital, Inc. and Centurion One Capital Corp. will act as placement agents, in connection with a PIPE. Latham & Watkins LLP and Gowling WLG (Canada) LLP are acting as legal counsels to Above Food. Greenberg Traurig LLP is acting as legal counsel to Bite. About Above Food Above Food Corp. is a differentiated, regenerative ingredient company that celebrates delicious products made with real nutritious, flavorful ingredients and delivered with transparency. Above Food’s vision is to create a healthier world — one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, Above Food delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food’s consumer products and brands are available online at www.abovefood.com and in leading grocers across Canada and the United States. About Bite Acquisition Corp. Bite Acquisition Corp is a special purpose acquisition company formed for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Bite is led by Chair and CEO Alberto Ardura and a team of successful industry executives, and venture capital investors who have long track records of operating business in the restaurant and food industries. Cautionary Statement Regarding Forward-Looking Statements Certain statements included in this Press Release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or events that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics and projections of market opportunity. These statements are based on various assumptions, whether or not identified in this Press Release, and on the current expectations of Above Food’s and Bite’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Above Food and Bite. These forward-looking statements are subject to a number of risks and uncertainties, including (i) changes in domestic and foreign business, market, financial, political and legal conditions; (ii) the inability of the parties to successfully or timely consummate the proposed Business Combination, including the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company, the expected benefits of the proposed Business Combination or that the approval of the stockholders of Bite or Above Food is not obtained, any of the other conditions to closing are not satisfied or that events or other circumstances give rise to the termination of the business combination agreement relating to the proposed Business Combination; (iii) changes to the structure of the proposed Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining the necessary regulatory approvals; (iv) the ability to meet stock exchange listing standards following the consummation of the proposed Business Combination; (v) the risk that the proposed Business Combination disrupts current plans and operations of Above Food as a result of the announcement and consummation of the proposed Business Combination; (vi) failure to realize the anticipated benefits of the proposed Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (vii) costs related to the proposed Business Combination; (viii) changes in applicable law or regulations; (ix) risks relating to the uncertainty of the projected financial information with respect to Above Food; (x) the outcome of any legal proceedings that may be instituted against Bite or Above Food; (xi) the effects of competition on Above Food’s future business; (xii) the impact of the COVID-19 pandemic on Above Food’s business; (xiii) the ability of Bite or the combined company to issue equity or equity-linked securities or obtain debt financing in connection with the proposed Business Combination or in the future; (xiv) the enforceability of Above Food’s intellectual property rights, including its copyrights, patents, trademarks and trade secrets, and the potential infringement on the intellectual property rights of others; (xv) Above Food’s ability to execute its planned acquisition strategy, including to successfully integrate completed acquisitions and realize anticipated synergies; and (xvi) those factors discussed under the heading “Risk Factors” in Bite's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the SEC on March 11, 2024, the Registration Statement and other documents filed, or to be filed, by Bite and/or New Above Food with the SEC. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that none of Bite or Above Food presently know or that Bite or Above Food currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Bite’s and Above Food’s expectations, plans or forecasts of future events and views as of the date of this Press Release. Bite and Above Food anticipate that subsequent events and developments may cause Bite’s and Above Food’s assessments to change. However, while Bite and Above Food may elect to update these forward-looking statements at some point in the future, Bite and Above Food specifically disclaim any obligation to do so. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. Accordingly, undue reliance should not be placed upon the forward-looking statements. Certain market data information in this Press Release is based on the estimates of Above Food and Bite management. Above Food and Bite obtained the industry, market and competitive position data used throughout this Press Release from internal estimates and research as well as from industry publications and research, surveys and studies conducted by third parties. Above Food and Bite believe their estimates to be accurate as of the date of this Press Release. However, this information may prove to be inaccurate because of the method by which Above Food or Bite obtained some of the data for its estimates or because this information cannot always be verified due to the limits on the availability and reliability of raw data and the voluntary nature of the data gathering process. Important Information This press release does not contain all the information that should be considered concerning the proposed Business Combination and is not intended to form the basis of any investment decision or any other decision in respect of the proposed Business Combination. Investors and security holders and other interested parties are urged to read the Registration Statement, including any amendments thereto, and any other documents filed with the SEC when they become available, carefully and in their entirety because they will contain important information about Bite, Above Food and the proposed Business Combination. Investors and security holders may obtain free copies of the Registration Statement and the definitive proxy statement to be incorporated by reference therein and filed in connection with the Business Combination (when available) and other documents filed with the SEC by Bite or New Above Food through the website maintained by the SEC at http://www.sec.gov. These documents (when they are available) can also be obtained free of charge from Bite upon written request to Bite by emailing alberto@biteacquisitioncorp.com. The definitive proxy statement will also be mailed to holders of Bite’s common stock in connection with Bite’s solicitation of proxies for the vote by Bite’s stockholders regarding the proposed Business Combination and related matters. Participants in the Solicitation Bite and Above Food and their respective directors and certain of their respective executive officers, other members of management and employees, under SEC rules, may be considered participants in the solicitation of proxies with respect to the proposed Business Combination. Information about the directors and executive officers of Bite is included in Bite’s Annual Report on Form 10-K, filed with the SEC on March 11, 2024, which is available free of charge at the SEC’s website at www.sec.gov. Additional information regarding the participants in the proxy solicitation and a description of their direct interests, by security holdings or otherwise, is set forth in the Registration Statement and other relevant materials to be filed with the SEC regarding the proposed Business Combination by Bite or New Above Food. Stockholders, potential investors and other interested persons should read the Registration Statement carefully before making any voting or investment decisions. These documents, when available, can be obtained free of charge from the sources indicated above. No Offer or Solicitation This communication is for informational purposes only and is not intended to and shall not constitute an offer to sell or exchange, or the solicitation of an offer to sell, exchange, buy or subscribe for any securities or a solicitation of any vote of approval, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law. Contacts Media: media@abovefood.com Investors: investors@abovefood.com

April 04, 2024 09:00 AM Eastern Daylight Time

Downtown Music Holdings (DMH) Completes Global Integration, Supporting Over 4 million Artists and 5,000 Business Clients in 150 Countries

Downtown Music Holdings

Downtown Music Holdings (DMH), the world’s largest independent service provider to the global music industry, announced today the completion of its integration strategy across its business-to-business and creator-focused businesses into a single operating company. The complete integration, including the merger of CD Baby’s operations into Downtown Music, further expands access to Downtown’s full spectrum of services to the entire global music industry. Downtown currently supports over 4 million artists and 5,000 business clients in 150 countries who collectively generated over 1.5 trillion streams across major streaming platforms in 2023. Downtown clients won nearly 30% of the awards at the 2024 GRAMMYs. As part of the integration, Downtown Music Holdings named Pieter van Rijn CEO of Downtown Music, reporting into Andrew Bergman, Downtown Music Holdings CEO. Based in Amsterdam and New York, van Rijn brings a wealth of experience and a proven track record of leadership within the organization and the industry. He previously served as the Group President of Downtown Music and as CEO of FUGA, which was acquired by DMH in 2020. He was appointed to the Downtown Music Holdings board in 2023. “The integration of all of our products and services under the Downtown Music umbrella alongside Pieter’s stewardship is a truly energizing moment in our journey. We bring together all the critical services that creators and businesses need to navigate the modern music industry. I’m proud of the organization we’ve scaled and look forward to capitalizing on the exciting opportunities before us,” said Andrew Bergman, CEO of Downtown Music Holdings. “This is an extraordinary time for Downtown Music as we enter this next phase as a fully unified operating company. The thousands of businesses that we support at Downtown Music and the millions of trusted creators at CD Baby will now benefit from our industry-leading suite of tools and services within a single organization. I look forward to continuing to work closely with Andrew and the DMH Board in delivering this enhanced offering to all our customers, ” said Pieter van Rijn, CEO of Downtown Music. About Downtown Music Downtown Music is the business and professional services division under Downtown Music Holdings, the world’s leading music services company with over 2 million clients in over 145 countries with a catalog of over 38 million music assets in a wide variety of genres and languages. Downtown’s service offerings support creators and businesses in all facets of the music industry including music creation, publishing distribution, marketing, royalty collection, financing, accounting and payment services. Contact Details Kite Hill PR downtownmusic@kitehillpr.com Company Website https://www.downtownmusic.com/

April 04, 2024 09:00 AM Eastern Daylight Time

Apple Rush Company, Inc. Releases Shareholder Letter to Paint a Picture of the Last Year and the Plans Moving Forward

Apple Rush Company, Inc.

Orlando, FL - April 04, 2024 - Apple Rush Company, Inc. (APRU), a leading player in the functional beverage industry, proudly announces its update from last year and the plans moving forward for 2024. Dear APRU Shareholders, I trust this letter finds you in good health and high spirits. As we embark on a new phase of growth and innovation, I am excited to share with you the multitude of strategic initiatives and developments that have unfolded at APRU during the past fiscal year. The Apple Rush Company has embarked on an ambitious path remodeling itself from a private label co-packer and brand owner utilizing co-packers for our own production to a full-service production company. Since the commencement of manufacturing operations at Lena Brewing in November 2023, our collaboration with Mitra-9 has achieved unprecedented success. We started with a test run of 20,000 cans of Mitra-9's kava beverage in November and moved to the kratom beverage in December. Our production swiftly escalated to 50,000 cans in December and January and February. Our production schedule for March is in excess of 70,000 cans and the introduction of new equipment at the brewery is set to elevate production to an impressive 300,000 cans per month by spring. Lena Brewing's staff has remarkable efficiency, boasting a 92% efficiency rate, and has been instrumental in meeting explosive demand, with projections forecasting a meteoric rise to one million units monthly by the end of 2024. Our botanical extraction and production is moving ahead at a rapid pace. We have developed our own technology that provides us with the capability to recover 99.5% of the organic solvents we utilize in the process. Our finished extract is highly sought after with multiple companies seeking additional production from us that would allow for as much as a 10x in increased revenue from last year. Expansion of our plant to fulfill these backorders is in process and we are on target to hit our earlier projections. We are in the process of launching several new innovative retail products that we believe are game changers in the industry with a chewable tablet and our own shots and beverages. The expansion in production will allow us to continue in the development of our own products and our technology can be utilized with any botanical product, not limited to our existing lines. Our core brands of Apple Rush and Element Brands are going to be coming soon. We have been approved to put Apple Rush back on Amazon and on a couple other platforms that will be announced soon. Our marketing efforts are being focused and we believe that timing is right to make the investment in inventory and exposure to the brands. We also are going to be expanding on our belief of responsible serving sizes for all our products. There have been a lot of changes in the hemp industry and our plans are to be on the front side of responsibility and leading the way with innovative offerings. We have decided to follow a very conservative approach in our products and are utilizing our own technologies that provide higher bioavailability of the active ingredients so that we can prove responsibility. It is never our intent to create additional addicts with our products but to transition people from pharmaceuticals to a healthier plant based alternative health therapeutic solution and eventually completely off of the product if they desire. As a company, we will never aim to sell a product based on how much active ingredient is in it but based totally on the results that the products deliver. We have been discussing the potential of either partnering or creating our own facilities to educate the public on the use and benefits of a plant based holistic style health regimen. We are working on several other projects with testing of both kratom and hemp products with a group of veterans. This testing is to verify internal results of a sleep tablet and pain tablet for use as an alternative to pharmaceuticals. It is a blind study being done by a doctor that currently treats veterans with PTSD. This program will lead to another program being evaluated by a major University and a nonprofit organization we are working with. We have added a lot of talent to our team with Ross Vehmeier leading the Lena Brewing operation and spearheading the production of all of our unique beverages. With Ross leading this team we have initiated a business plan with the intent to expand Lena to as many as 8 brewing operations over the next five years. Ross’ experience in multi-unit hospitality management and also being a serial entrepreneur brings this possibility to Apple Rush in a truly meaningful way. We should be able to become a true national player with any brand we decide to build through our own production capabilities. We also have a talented team of scientists at Alkhemical Roots that has driven our initiatives in the plant therapeutics space with our own extraction processes that are unique to what we do and provide higher efficacy than many of the existing products in the botanical space. Our team has over 25 years of extraction technology development and has spent millions of dollars developing clean botanical solutions. We intend to change our executive staff in 2024 and 2025 with the addition of a financial officer, president, and several other positions on our advisory board and the addition of independent directors. Our plans are to attempt to raise as much as twenty million dollars with our preferred class of stock. We know this process will take some time and effort, but we believe that with the new business model of owning our own production capacity, we should be able to deliver the results needed for our shareholders. Apple Rush Company receives regular requests to produce beverages and other products for private label customers and we believe that over the next 12 to 24 months we will expand to several other new products that consumers will desire to obtain. Our capabilities include alcoholic beverages, coffee beverages, sodas, juices, and other functional beverages. With all of the projects and acquisitions we have moving forward in 2024, we believe that we could possibly generate revenues in excess of 20 million dollars per year by mid 2025. Thank you again for being loyal shareholders and sticking with us through the tough times. The wait I am sure will be worth it and as a team we are excited to grow in 2024 and beyond. About The Apple Rush Company, Inc. The Apple Rush Company, Inc., through its subsidiary APRU, LLC, is a distributor of CPG products under the trademarked Apple Rush brand, Element brand and other labels. The Apple Rush brand has more than 50 years of existence in the natural beverage industry. As a historical leader in the organic and natural beverage sector our goal is to now become a leader in the distribution of anhydrous hemp oil products nationwide. For more information, please go to www.aprubrands.com, www.element-brands.com, elementk.kratomwave.store www.alkhemicalroots.com with our expanded product portfolio. Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise. www.aprubrands.com Contact Details Tony Torgerud +1 888-741-3777 dtorgerud@aprullc.com

April 04, 2024 08:00 AM Eastern Daylight Time

Classiq and Quantum Intelligence Corp (QIC, Korea) Partner On Quantum Accelerated Drug Development

Classiq Technologies

Classiq, a leading quantum computing software company, and Quantum Intelligence Corp. ( QIC, Korea ) today announced the launch of innovative joint research to accelerate drug development by applying quantum computing to pharmacology. The collaboration is under the auspices of Classiq’s Quantum Computing For Life Sciences & Healthcare Center, launched with NVIDIA last year. This new partnership is dedicated to utilizing the Classiq platform to explore the use of quantum computing in pharmacology for a wide range of predictive and analytical applications. This includes the discovery and design of novel drug candidates as well as the prediction of potential side effects and interactions. The partnership focuses on significantly enhancing the efficiency and accuracy of drug development by integrating Classiq's quantum computing platform with QIC's drug development platform. “Quantum Intelligence diverges from the traditional route of biopharmaceutical companies, positioning itself more as a platform company powered by quantum and AI technology,” stated QIC's CEO, Hwanho Choi, MD., PhD. “Through this unique collaborative approach, we aim to precisely identify potential side effects early on, reducing risks across all stages of drug development and clinical trials.” QIC, a South Korean startup pioneering the QUEST-ADMET platform based on quantum computing and AI technologies, targets prediction of compound properties through electronic charge distribution algorithms, to efficiently assess therapeutic solution efficacy and safety of drug candidates. Classiq offers a leading quantum development platform with unique technology enabling high-level abstraction that simplifies and accelerates development of efficient complex quantum software and applications. The Classiq platform’s built-in functions, GitHub repository and seamless execution on quantum computing hardware, will be key components in the research to develop pharmacology applications for research. “This agreement marks a significant step towards a new era of accelerated drug development using quantum computing technology,” said Classiq’s CEO Nir Minerbi. “By combining Classiq's quantum computing technology with QIC's drug development platform, we target significant improvements in the efficiency and accuracy of drug development.” About Classiq Classiq Technologies, the leading quantum software company, provides an all-encompassing platform (IDE, compiler and OS) with a single point of entry into quantum computing, taking users from algorithm design to execution. The high-level descriptive quantum software development environment, tailored to all levels of developer proficiency, automates quantum programming. This ensures that a broad range of talents, including those with backgrounds in AI, ML and linear algebra, can harness quantum computing without requiring deep, specialized knowledge of quantum physics. Classiq democratizes access to quantum computing and equips its users to take full advantage of the quantum computing revolution, including access to a broad range of quantum hardware. Classiq’s core technology, algorithmic quantum circuit compilation, is engineered to power the quantum ecosystem of today and the future. Classiq works closely with quantum cloud providers and advanced computation hardware developers providing software for use with quantum computers, HPC and quantum simulators. Backed by investors such as HPE, HSBC, Samsung, Intesa Sanpaolo and NTT, Classiq’s world-class team of scientists and engineers has distilled decades of quantum expertise into its groundbreaking quantum engine. Follow Classiq on LinkedIn, X (formerly Twitter) or YouTube, and visit the Slack community and website, www.classiq.io to learn more. About Quantum Intelligence Corp. (QIC) Founded in 2020 by CEO Dr. Choi Hwanho and CTO Dr. Kang Hong-seok, Quantum Intelligence Corp. (QIC), based in Seoul, South Korea, is at the forefront of integrating quantum computing with artificial intelligence to revolutionize drug discovery. Using its advanced QUEST-ADMET platform and the Quantum-Dock module, QIC aims to outperform conventional drug development approaches in both accuracy and speed, offering highly precise predictions of drug efficacy and safety. QIC's global expansion is supported by strategic partnerships, including collaborations with Oxford Quantum Circuits (UK), Quandela (France), and QuEra Computing (US), alongside a joint venture with 48Hour Discovery (Canada). These partnerships enhance QIC's presence in key North American, European and Asian markets. The collaborations are aimed at improving pharmacological predictions, discovering new drug candidates and investigating metalloprotein-ligand interactions and pharmacokinetics. Beyond healthcare, QIC is also exploring quantum computing's potential in the financial sector, aiming to transform algorithmic trading, risk analysis and asset management. QIC's diverse team of experts in quantum physics, molecular modeling and AI is committed to driving innovations that optimize the drug development process. These efforts have established QIC as a prospective leader in quantum drug discovery, aiming to reduce development costs and timelines while improving drug safety and efficacy. The company's strategy to license out drug candidates developed with its quantum computing technology marks a paradigm shift in the pharmaceutical industry, underscoring Quantum Intelligence's potential for significant growth. Contact Details Rainier Communications on behalf of Classiq Michelle Allard McMahon classiqPR@rainierco.com Quantum Intelligence Corp. (QIC) Byung-Hoon Kim, Operations Manager hoon.kim@qic.ai Company Website http://www.classiq.io/

April 04, 2024 08:00 AM Eastern Daylight Time

Bacula Systems Corp Appoints Aristide Caraccio as President & CEO

Bacula Systems

Expanding its leadership in high security backup and recovery for HPC and demanding IT environments, Bacula Systems today named Aristide Caraccio, its Senior VP of Sales and Marketing, as President & CEO of Bacula Systems Corp. “Aristide is a dynamic, values-driven business leader who has a diverse background of experiences and an excellent track record of delivery in the IT industry. He has led Bacula’s sales and marketing activities worldwide for some years now and helped build the industry leading reputation we have for customer satisfaction in some of the world’s most security conscious and demanding organizations worldwide. The Board looks to Aristide to further develop the organization to realize the full potential of Bacula Systems Corp, delivering growth and value for its customers, employees and shareholders”, said Frank Barker, Chairman of Bacula Systems SA. Caraccio joined Bacula in 2011, and has been instrumental in developing Bacula’s customer base in the United States and globally, including large organizations such as NASA, Warner Bros. Discovery and Navisite. “I am excited by Bacula’s unique ability to protect large, complex and high performance IT environments, and its disruptive positioning in helping users to avoid vendor lock-in. The opportunity for Bacula has never been bigger than it is today and I am honored to lead Bacula Systems Corp as it helps organizations to modernize their backup strategy, lower costs, and achieve much better protection against ransomware and other attacks”, said Caraccio. “I am delighted to have Aristide leading Bacula Systems Corp. His vision and drive will help us to bring a more secure, flexible, scalable, powerful and cost-effective backup and security solution to more customers so they can replace outdated and overpriced legacy backup systems. Aristide has the right industry and commercial knowledge to leverage our unique software and lead Bacula Systems Corp as it further develops market share in North America, Canada and Latin America”, said Gopal RajGuru, CEO of Bacula Systems SA. About Bacula Systems: Bacula Enterprise is a highly scalable backup and recovery software for large organizations, data centers and MSPs. www.baculasystems.com Contact Details Rob Morrison rob.morrison@baculasystems.com +41 21 641 60 80 rob.morrison@baculasystems.com Company Website https://www.baculasystems.com/

April 04, 2024 07:17 AM Eastern Daylight Time

BestGrowthStocks.Com Issues Comprehensive Evaluation of MultiSensor AI Holdings Inc.

MultiSensor AI Holdings

NEW YORK, NY / NewsDirect / April 4th, 2024 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a comprehensive evaluation of MultiSensor AI Holdings Inc. a pioneer in AI-powered industrial maintenance and process control solutions. MultiSensor AI Holdings Inc. (NASDAQ: MSAI) has recently caught the attention of many investors following the release of the next generation of its flagship software, SmartIR. The release of SmartIR 2.0 marks a significant milestone for MultiSensor AI Holdings. Best Growth Stock's full report breaks through the noise and offers an extensive comprehensive evaluation of MultiSensor AI Holdings technology, potential catalysts, current estimated share structure, cash position, recent developments, and how they relate to potential future catalysts, financial performance, and much more. Access this full analysis free: https://bestgrowthstocks.com/access-msai-analysis/ (If you cannot click the link above, copy and paste to your browser may be required) Access this full analysis free: https://bestgrowthstocks.com/access-msai-analysis/ (If you cannot click the link above, copy and paste to your browser may be required) About MultiSensor AI MultiSensor AI provides turnkey predictive maintenance and process control solutions, which combine cutting edge imaging and sensing technologies with AI-powered enterprise software. Powered by AWS, MSAI's software leverages a continuous stream of data from thermal imaging, visible imaging, acoustic imaging, vibration sensing, and laser sensing devices to provide comprehensive, real-time condition monitoring for a customer's critical assets, processes, and manufactured outputs. This full-stack solution measures heat, vision, vibration, and gas in the surrounding environment, helping companies gain predictive insights to efficiently and proactively manage their asset reliability and manufacturing processes. MSAI's cloud and edge solutions are deployed by organizations to protect critical assets across a wide range of industries including distribution & logistics, manufacturing, utilities, and oil & gas. For more information, please visit https://www.multisensorai.com About Best Growth Stocks Best Growth Stocks is a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing our exclusive ai-assisted research. BGS is also a financial news provider, focused on giving investors direct access to CEOs of promising, publicly-traded companies, and market experts. Our CEO interviews aim to answer the questions that rest on the minds of current and future shareholders. This is not to be construed as financial advice. Please consult with a licensed financial advisor before making any investment decisions. Contact Details Best Growth Stocks Steve Macalbry Editor@bestgrowthstocks.com

April 04, 2024 07:00 AM Eastern Daylight Time